Search Results
Results found for "Sai Prasad Pydi"
- Fluorescence Polarization in GPCR Research
References Kumar V, Chunchagatta Lakshman PK, Prasad TK, Manjunath K, Bairy S, Vasu AS, Ganavi B, Jasti
- Science Needs Rigor, But Also Joy
And that moment, silly as it was, says a lot about how he sees science.
- The Chemistry of Confidence: Aha Moments That Shape Scientific Careers
Saying yes to a postdoc opportunity abroad.
- From Pipettes to Platforms: The Evolution of GPCR Research
Like many, it was a mix of opportunity, timing, and the courage to say yes before everything was figured Technical mastery opened doors, but what kept her moving was knowing when to say yes before everything
- How GPCR Spatial Signaling Sparked a Scientific Journey
I didn’t expect to love it, says Michelle Halls. But luck only works if you say yes when the door opens.
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
Proven frameworks used in real discovery programs On-demand lessons built for tight research schedules A say Access this week’s full Premium Edition here ➤ What our members say "Thank you for bringing this course
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
“You can try, try, try—and fail, fail, fail,” Eric says. “Don’t over-rationalize,” he says. At early stages, breadth matters more than precision.
- Ben Clements on Rescuing Opioids with GPCR Modulators
where the excitement lies: "There’s so much space left to explore in GPCR-targeted modulation," he says
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
From t-tests to ANOVA and F-tests, know which tool to apply when, so debates about “what the graph says Access this week’s full Premium Edition here ➤ What our members say 🗣️ "The content had enough depth
- Curve Shifts Don’t Lie, But Your Eyes Might
No more arguments about “what the graph seems to say.” You’ll move from “I think” to “I know.” The literature says 7.5. Is that consistent, or is your assay biased?
- From Snapshots to Predictions: Why Mechanism of Action Matters
You can say what the drug “seems” to do, but not what it will do elsewhere. Models are the bridge. Instead of saying, “This looks like partial agonism” , you can ask: What happens if concentration increases
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
Please don't say we didn't give you a heads-up! s dive into the Classified GPCR News from November 25th to December 1st, 2024 Industry News Amgen says
- Adhesion GPCR Consortium Newsletter - May 2024
As much as I was shocked that I wasn’t asked if I was a student or a PI, I was more proud to say that suadero (pronounced swa-day-ro), fatty, with meat caramelized in its own fat, tender, and—oh, did I say
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
Read the Premium edition here ➤ What our members say 🗣️ "Dr.
- How System-Level GPCR Thinking Prevents Discovery Failures
👉 Access this week’s full Premium Edition here ➤ What Members Say "I am a convert! I will keep Dr.
- How Schild Analysis Protects Your Conclusions in GPCR Research
👉 Access this week’s full Premium Edition here ➤ What Members Say “Dr.
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
Access this week’s full Premium Edition here ➤ What our members say "I am a convert!
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Register for Discovery On Target ➤ What our community is saying “I enjoy the breadth of questioning that
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
Access this week’s full Premium Edition here ➤ What our members say "Thank you for bringing this course
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Potency does not,” says Kenakin.
- Understanding Enzyme Inhibition In GPCR Discovery Programs
Access this week’s full Premium Edition here ➤ What our members say "The content had enough depth to
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
Access this week’s full Premium Edition here ➤ What our members say "Dr.
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Access this week’s full Premium Edition here ➤ What our members say 🗣️ "The best pharmacology teacher
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
Access this week’s full Premium Edition here ➤ What our members say 🗣️ “The best pharmacology teacher
- 📰 GPCR Weekly News, June 5 to 11, 2023
Berchiche is at the Molecular Pharmacology GRC, if you are also on-site, please stop by and say hi.
- How to Avoid the Most Common Gaps in Your Biotech Pitch
A strong biotech pitch isn’t about saying more.
- GPCR Collaboration: From Models to Medicine
If docking can suggest binding modes but can’t resolve nanomolar potency differences, they say so.
- 📰 GPCR Weekly News, May 6 to 12, 2024
Binders, Drugs, and more A relaxin receptor gene RpGPCR41 is involved in the resistance of Rhopalosiphum padi
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
👉 Access this week’s full Premium Edition here ➤ Hear What Our Members Are Saying “The content had enough
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
No one wants to say it out loud. You end up running two strategies in parallel . One in your deck.
